Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and ...

One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but ...

The partners plan to build evidence packages that standardize comprehensive genomic profiling and other molecular testing ...

CFO Joe Wolk, who revealed the figure Tuesday morning on CNBC, told investors the charge was primarily in the healthcare ...

The Illinois attorney general said the deal represents a “troubling trend of wealthy investors attempting to limit ...

Johnson & Johnson plans to seek a U.S. indication for multiple general surgery procedures, including gastric bypass, which ...

Johnson & Johnson’s electrophysiology unit struggled in the first quarter, as the company chases Medtronic and Boston ...

The cuts to the FDA are just one piece of the budget proposal, which looks to slash the HHS’ discretionary spending by ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

The Commerce Department has begun a so-called Section 232 investigation into the national security effects of the U.S.

CEO Robert Ford told investors the company had considered raising its earnings forecast for 2025, but decided to maintain it in light of the new tariffs.

The U.S. Commerce Department has initiated a Section 232 investigation into semiconductor imports, according to a filing to be published in the Federal Register Wednesday.